Provided by Tiger Fintech (Singapore) Pte. Ltd.

Larimar Therapeutics, Inc.

2.68
+0.22008.94%
Post-market: 2.790.1100+4.10%18:47 EDT
Volume:1.23M
Turnover:3.30M
Market Cap:171.59M
PE:-1.80
High:2.78
Open:2.51
Low:2.47
Close:2.46
Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Larimar Therapeutics (LRMR) Gets a Buy from JMP Securities

TIPRANKS
·
19 Feb

Insiders Re-Evaluate Their US$522.0k Stock Purchase As Larimar Therapeutics Falls To US$215m

Simply Wall St.
·
12 Feb

Larimar Therapeutics Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $18

THOMSON REUTERS
·
29 Jan

Truist sees ‘significant upside’ for Larimar Therapeutics, starts with a Buy

TIPRANKS
·
29 Jan

Truist Initiates Larimar Therapeutics at Buy With $18 Price Target

MT Newswires Live
·
29 Jan

Larimar Therapeutics initiated with a Buy at Truist

TIPRANKS
·
29 Jan

Larimar Therapeutics Begins Dosing Adolescents in Friedreich's Ataxia Treatment Study

MT Newswires Live
·
24 Jan

Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-in Study for Patients With Friedreich’s Ataxia

THOMSON REUTERS
·
24 Jan

Larimar Therapeutics Inc - to Initiate Cohort of Children 2-11 Years Old in 1H 2025

THOMSON REUTERS
·
24 Jan

SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia

Zacks
·
08 Jan

Oppenheimer Reaffirms Their Buy Rating on Larimar Therapeutics (LRMR)

TIPRANKS
·
17 Dec 2024

Larimar Therapeutics announces initial data from OLE study of nomlabofusp

TipRanks
·
17 Dec 2024

Market ‘misinterpreting’ Larimar data, selloff ‘overdone,’ says Citi

TIPRANKS
·
17 Dec 2024

Analysts Offer Insights on Healthcare Companies: Larimar Therapeutics (LRMR) and Ascendis Pharma (ASND)

TIPRANKS
·
17 Dec 2024

Larimar Therapeutics selloff a buying opportunity, says JonesResearch

TIPRANKS
·
17 Dec 2024

Larimar Therapeutics trading resumes

TIPRANKS
·
16 Dec 2024

Larimar Therapeutics trading halted, volatility trading pause

TIPRANKS
·
16 Dec 2024

Larimar Therapeutics Says Early Data From Friedreich's Ataxia Study Suggest Better Clinical Outcomes

MT Newswires Live
·
16 Dec 2024